SkyKnight Capital Fund II, L.P. - Mar 11, 2022 Form 4 Insider Report for AdaptHealth Corp. (AHCO)

Role
Director
Signature
SkyKnight Capital Fund II, L.P, By: SkyKnight Capital II GP, LLC, its manager, By: /s/ Matthew Ebbel, Title: Managing Member
Stock symbol
AHCO
Transactions as of
Mar 11, 2022
Transactions value $
$652,201
Form type
4
Date filed
3/15/2022, 05:01 PM
Previous filing
Mar 8, 2022
Next filing
May 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AHCO Class A Common Stock Purchase $271K +17.5K +0.72% $15.50 2.46M Mar 11, 2022 Direct F1
transaction AHCO Class A Common Stock Purchase $381K +25K +1.02% $15.25 2.48M Mar 14, 2022 Direct F1, F2
holding AHCO Class A Common Stock 5.66M Mar 11, 2022 By SkyKnight Aero Holdings, LLC F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held by SkyKnight Capital Fund II, L.P. "("SkyKnight Fund II"). SkyKnight Capital II GP, LLC ("SkyKnight II GP") is the general partner of SkyKnight Fund II. Matthew Ebbel is the managing member of SkyKnight II GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.
F2 The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $15.21 to $15.25. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.
F3 Shares held by SkyKnight Aero Holdings, LLC ("SkyKnight Aero Holdings"). SkyKnight Capital, L.P. ("SkyKnight Capital") is the manager of SkyKnight Aero Holdings. SkyKnight Capital Management, LLC ("SkyKnight Capital Management") is the general partner of SkyKnight Capital. Matthew Ebbel is the managing member of SkyKnight Capital Management. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.

Remarks:

Theodore B. Lundberg has been deputized to represent the Reporting Persons on the board of directors of the Issuer. By virtue of Mr. Lundberg's representation, for purposes of Section 16 of the Securities Exchange Act of 1934 (the "Exchange Act"), each of the Reporting Persons may be deemed directors by deputization of the Issuer. This filing shall not be deemed an admission that any Reporting Person is a beneficial owner of the securities reported in this filing for purposes of Section 16 of the Exchange Act or otherwise, or is subject to Section 16 of the Exchange Act, and each Reporting Person disclaims beneficial ownership of these securities, except to the extent of such Reporting Person's pecuniary interest therein, if any.